Results: Breast Cancer

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Mb ***
Hr ***
Brca1 **
Brca2 *
Mri *
Dnpep *
Sfrp1 *
Rara *
Atp2a3 *
Trpc1 *
Znf217 *
Tsc2 *
Yy1 *
Cdc20 *
Eif4a3 *
Pik3ca *
Nbn *
Pfkp *
Pdcd4 *
Cck *
Impact n.s.
Rad51c n.s.
Esr1 n.s.
Sln n.s.
Ctrl n.s.
Erbb3 n.s.
Msn n.s.
Nrf1 n.s.
Cdk12 n.s.
Ubc n.s.
She n.s.
Erbb2 n.s.
Cyp2b6 n.s.
Cd44 n.s.
Epcam n.s.
Fancd2 n.s.
Cd24 n.s.
Rad51d n.s.
F3 n.s.
Pigr n.s.
Nodal n.s.
Chek2 n.s.
Mki67 n.s.
Cdk6 n.s.
Cpm n.s.
Bax n.s.
Mip n.s.
Ado n.s.
Cdk4 n.s.
Ccnd1 n.s.
Por n.s.
Abcg2 n.s.
Pgr n.s.
Pcna n.s.
Cxcr4 n.s.
Rad51 n.s.
Abcb1 n.s.
Pms2 n.s.
Stk11 n.s.
Cd47 n.s.
Cd28 n.s.
Twist1 n.s.
Palb2 n.s.
Ahr n.s.
Stat3 n.s.
Bad n.s.
Akr1c3 n.s.
Cyp2j2 n.s.
Adamts1 n.s.
Recql n.s.
Ror1 n.s.
Rhoc n.s.
Fbln5 n.s.
Ankrd12 n.s.
Nmu n.s.
Zeb2 n.s.
Il1rl2 n.s.
Sirpb1 n.s.
Recql5 n.s.
Zpld1 n.s.
Lrr1 n.s.
Spock1 n.s.
Odf3b n.s.
Spp2 n.s.
Map9 n.s.
Greb1 n.s.
Cd9 n.s.
Slc38a2 n.s.
Abcb5 n.s.
Fam129b n.s.
Ska1 n.s.
Paqr4 n.s.
Cd81 n.s.
Dnajb4 n.s.
Fam64a n.s.
Ajap1 n.s.
Kmt2c n.s.
Ntrk3 n.s.
Pfkfb4 n.s.
Usp4 n.s.

Top Ranked Key Phrases

Triple negative breast cancer tnbc ***
Ptx resistant bc cell lines ***
Breast cancer resistance protein bcrp ***
Triple negative breast cancer ***
Breast cancer cell lines ***
Epithelial mesenchymal transition emt ***
Her2 positive breast cancer ***
Human breast cancer cells ***
Disease free survival dfs ***
Early stage breast cancer ***
Mcf 7 breast cancer cells ***
Body mass index bmi ***
Hormone receptor positive ***
Kaplan meier method ***
Estrogen receptor er ***
Progesterone receptor pr ***
Cell cycle arrest ***
Cancer cell lines ***
Cd8 t cells ***
Human breast cancer ***
Mesenchymal transition emt ***
Tnbc cell lines ***
Body mass index ***
Disease free survival **
Invasive breast cancer **
Metastatic breast cancer **
Dose dependent manner **
Advanced breast cancer **
Breast cancer bc **
Early breast cancer **
Including breast cancer **
Primary breast cancer **
Female breast cancer **
Breast conserving surgery **
Breast cancer cells **
Er pr tumours **
Breast cancer survivors **
Breast cancer therapy **
Breast cancer screening **
Breast cancer tissues **
Mda mb 231 cells **
Breast cancer subtypes **
Breast cancer risk **
Independent prognostic factor **
Cell cycle progression **
Mcf 7 adr cells **
Real time pcr **
Breast cancer metastasis **
Western blot analysis **
Breast cancer treatment **
Breast cancer progression **
Overall survival os **
Breast cancer incidence **
95% confidence intervals cis **
Potential therapeutic target **
Breast cancer diagnosis **
Breast cancer patients **
Breast cancer cases **
Triple negative **
Present study was **
Breast cancer development **
Neoadjuvant chemotherapy nac *
95% confidence interval ci *
Cell lines *
Nf Κb *
Present study aimed *
Dna repair *
Breast density n.s.
Cell cycle n.s.
Dna damage n.s.
4t1 cells n.s.
Cell growth n.s.
Ductal carcinoma n.s.
Mammographic density n.s.
Cyclin d1 n.s.
Breast cancer n.s.
Vitamin d n.s.
Breast reconstruction n.s.
Tumor suppressor n.s.
Odds ratio n.s.
Significantly different n.s.
Significantly higher n.s.
Tumor tissue n.s.
Bc cells n.s.
Significantly lower n.s.
Cancer cells n.s.
Breast mri n.s.
Normal cells n.s.
Protein levels n.s.
Bc survivors n.s.
Tumor growth n.s.
Metastatic disease n.s.
Positive margins n.s.
Mda mb 231 n.s.
Cell proliferation n.s.
Tumor cells n.s.
Cancer survivors n.s.
Advanced stage n.s.
Rt pcr n.s.
Risk factor n.s.

Top Ranked Mesh Terms

Breast neoplasms **
Mammography *
Health behavior *
Estrogen antagonists *
Extracellular matrix proteins *
Disease-free survival *
Receptors estrogen *
Receptor erbb-2 *
Mammary neoplasms animal *
Disease progression *
Neoplasm staging *
Bone neoplasms *
Cd8-positive t-lymphocytes *
Early detection of cancer n.s.
Lymphatic metastasis n.s.
Quality of life n.s.
Magnetic resonance imaging n.s.
Tamoxifen n.s.
Age factors n.s.
Antineoplastic agents hormonal n.s.
Treatment outcome n.s.
Cell adhesion n.s.
Mastectomy n.s.
Tumor suppressor proteins n.s.
Tomography x-ray computed n.s.
Epithelial cells n.s.
Neoplasm recurrence local n.s.
Mice transgenic n.s.
Mcf-7 cells n.s.
Antineoplastic agents n.s.
Nanoparticles n.s.
Incidence n.s.
Genetic predisposition to disease n.s.
Cell proliferation n.s.
Cell movement n.s.
Risk factors n.s.
Triple negative breast neoplasms n.s.
Kaplan-meier estimate n.s.
Adamts1 protein n.s.
Cadherins n.s.
Vimentin n.s.
Alcohol drinking n.s.
Tobacco smoke pollution n.s.
Social determinants of health n.s.
Sensitivity and specificity n.s.
Patient acceptance of health care n.s.
Insurance claim review n.s.
Medicare n.s.
Socioeconomic factors n.s.
Optimism n.s.
Perforator flap n.s.
Axilla n.s.
Mammaplasty n.s.
Breast cancer lymphedema n.s.
Prospective studies n.s.
Keratin-18 n.s.
Pyrans n.s.
Retinal detachment n.s.
Carcinoma ductal breast n.s.
Eye neoplasms n.s.
Steroid isomerases n.s.
Chondrodysplasia punctata n.s.
Androstenes n.s.
Anticholesteremic agents n.s.
Mice knockout n.s.
Transplantation n.s.
Morphogenesis n.s.
Stromal cells n.s.
Intracellular signaling peptides and proteins n.s.
Imaginal discs n.s.
Wnt proteins n.s.
Sleep initiation and maintenance disorders n.s.
United kingdom n.s.
Sleep n.s.
Synthetic lethal mutations n.s.
Protein structure quaternary n.s.
Drug resistance neoplasm n.s.
Radiotherapy intensity-modulated n.s.
Paclitaxel n.s.
Breast implants n.s.
Radiotherapy planning computer-assisted n.s.
Radiotherapy adjuvant n.s.
Drug resistance multiple n.s.
Depression n.s.
Patient satisfaction n.s.
Health care costs n.s.
Anxiety n.s.
Cost savings n.s.
Reoperation n.s.
Cost-benefit analysis n.s.
Mental health n.s.
Ambulatory surgical procedures n.s.
Breast n.s.
Cell survival n.s.
Seoul n.s.
Lymphocytes tumor-infiltrating n.s.
Perforin n.s.
Toll-like receptor 7 n.s.
Prostatic neoplasms castration-resistant n.s.
Bone density conservation agents n.s.

Results for: Breast Cancer

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes